153 related articles for article (PubMed ID: 23358112)
21. Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology.
Kitamura H; Yazawa T; Sato H; Okudela K; Shimoyamada H
Endocr Pathol; 2009; 20(2):101-7. PubMed ID: 19390995
[TBL] [Abstract][Full Text] [Related]
22. The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.
Kalari S; Jung M; Kernstine KH; Takahashi T; Pfeifer GP
Oncogene; 2013 Jul; 32(30):3559-68. PubMed ID: 22907430
[TBL] [Abstract][Full Text] [Related]
23. SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures.
Tlemsani C; Pongor L; Elloumi F; Girard L; Huffman KE; Roper N; Varma S; Luna A; Rajapakse VN; Sebastian R; Kohn KW; Krushkal J; Aladjem MI; Teicher BA; Meltzer PS; Reinhold WC; Minna JD; Thomas A; Pommier Y
Cell Rep; 2020 Oct; 33(3):108296. PubMed ID: 33086069
[TBL] [Abstract][Full Text] [Related]
24. Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas.
Sumi T; Hirai S; Yamaguchi M; Tanaka Y; Tada M; Yamada G; Hasegawa T; Miyagi Y; Niki T; Watanabe A; Takahashi H; Sakuma Y
Int J Oncol; 2018 Jul; 53(1):33-46. PubMed ID: 29658609
[TBL] [Abstract][Full Text] [Related]
25. Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas.
Zhang Y; Wang R; Li Y; Pan Y; Hu H; Zhang Y; Li H; Shen L; Yu Y; Sun Y; Chen H
J Thorac Oncol; 2015 Oct; 10(10):1444-50. PubMed ID: 26200450
[TBL] [Abstract][Full Text] [Related]
26. CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter.
Qiu Z; Zhu W; Meng H; Tong L; Li X; Luo P; Yi L; Zhang X; Guo L; Wei T; Zhang J
Theranostics; 2019; 9(16):4717-4729. PubMed ID: 31367252
[No Abstract] [Full Text] [Related]
27. POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.
Huang YH; Klingbeil O; He XY; Wu XS; Arun G; Lu B; Somerville TDD; Milazzo JP; Wilkinson JE; Demerdash OE; Spector DL; Egeblad M; Shi J; Vakoc CR
Genes Dev; 2018 Jul; 32(13-14):915-928. PubMed ID: 29945888
[TBL] [Abstract][Full Text] [Related]
28. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer.
He T; Wildey G; McColl K; Savadelis A; Spainhower K; McColl C; Kresak A; Tan AC; Yang M; Abbas A; Dowlati A
Mol Oncol; 2021 Jan; 15(1):195-209. PubMed ID: 33084222
[TBL] [Abstract][Full Text] [Related]
29. Distinct transcriptional programs of SOX2 in different types of small cell lung cancers.
Tenjin Y; Matsuura K; Kudoh S; Usuki S; Yamada T; Matsuo A; Sato Y; Saito H; Fujino K; Wakimoto J; Ichimura T; Kohrogi H; Sakagami T; Niwa H; Ito T
Lab Invest; 2020 Dec; 100(12):1575-1588. PubMed ID: 32801334
[TBL] [Abstract][Full Text] [Related]
30. PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Kanteti R; Nallasura V; Loganathan S; Tretiakova M; Kroll T; Krishnaswamy S; Faoro L; Cagle P; Husain AN; Vokes EE; Lang D; Salgia R
Lab Invest; 2009 Mar; 89(3):301-14. PubMed ID: 19139719
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of a mouse Clara cell-specific protein (mCC10) gene by the NKx transcription factor family members thyroid transciption factor 1 and cardiac muscle-specific homeobox protein (CSX).
Ray MK; Chen CY; Schwartz RJ; DeMayo FJ
Mol Cell Biol; 1996 May; 16(5):2056-64. PubMed ID: 8628271
[TBL] [Abstract][Full Text] [Related]
32. Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo.
Pruitt SC; Bussman A; Maslov AY; Natoli TA; Heinaman R
Gene Expr Patterns; 2004 Oct; 4(6):671-85. PubMed ID: 15465489
[TBL] [Abstract][Full Text] [Related]
33. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
[TBL] [Abstract][Full Text] [Related]
35. ASCL1 regulates the expression of the CHRNA5/A3/B4 lung cancer susceptibility locus.
Improgo MR; Schlichting NA; Cortes RY; Zhao-Shea R; Tapper AR; Gardner PD
Mol Cancer Res; 2010 Feb; 8(2):194-203. PubMed ID: 20124469
[TBL] [Abstract][Full Text] [Related]
36. A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells.
Poulsen TT; Pedersen N; Juel H; Poulsen HS
Cancer Gene Ther; 2008 Sep; 15(9):563-75. PubMed ID: 18421308
[TBL] [Abstract][Full Text] [Related]
37. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M
J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in histogenesis research of lung neuroendocrine cancers: Evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors.
Yazawa T
Pathol Int; 2015 Jun; 65(6):277-85. PubMed ID: 25708144
[TBL] [Abstract][Full Text] [Related]
39. Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo.
Liu Y; Zhang N; Wang Y; Xu M; Liu N; Pang X; Cao J; Ma N; Pang H; Liu L; Zhang H
Cancer Sci; 2012 Aug; 103(8):1420-8. PubMed ID: 22632166
[TBL] [Abstract][Full Text] [Related]
40. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
